Detalhe da pesquisa
1.
Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis.
Viruses
; 16(5)2024 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38793680
2.
XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections.
Cell Rep
; 42(2): 112123, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795562
3.
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.
Vaccine
; 41(35): 5072-5078, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460353
4.
Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation.
Cell Death Dis
; 14(12): 838, 2023 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110339
5.
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.
iScience
; 26(3): 106126, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748086
6.
Functional cure of a chronic virus infection by shifting the virus - host equilibrium state.
Front Immunol
; 13: 904342, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36110838